How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?
Public Health and Toxicology · 30.06.2026 · 6 (2) · 1-3
DOI: 10.18332/pht/225402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health and Toxicology, online erschienen am 30.06.2026. Verfasst von Maria Vlachou und 4 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Stillen
Abstract (Originalsprache)
bodies differ in their recommendations: some suggest that NRT may be used cautiously under medical supervision when behavioral strategies alone are insufficient, whereas others conclude that current evidence is insufficient to recommend for or against its routine use during pregnancy
Zitieren
APA
Vlachou, M., Kyrkou, G., Bakou, A., Vivilaki, V., & Diamanti, A. (2026). How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?. Public Health and Toxicology, 6(2), 1-3. https://doi.org/10.18332/pht/225402
Vancouver
Vlachou M, Kyrkou G, Bakou A, Vivilaki V, Diamanti A. How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?. Public Health and Toxicology. 2026;6(2):1-3. doi:10.18332/pht/225402
BibTeX
@article{Vlachou2026,
author = {Vlachou, Maria and Kyrkou, Giannoula and Bakou, Angeliki and Vivilaki, Victoria and Diamanti, Athina},
title = {How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?},
journal = {Public Health and Toxicology},
year = {2026},
volume = {6},
number = {2},
pages = {1--3},
doi = {10.18332/pht/225402}
}
EUVIMED